Simvastatin-induced rhabdomyolysis following cyclosporine treatment for uveitis

Ocular Immunology and Inflammation

Volumn 15, Issue 4, 2007, Pages 345-346

  Lasocki, Anita ^a   Vote, Brendan ^b   Fassett, Robert ^c   Zamir, Ehud ^a,d  

^a Royal Victorian Eye and Ear Hospital   (Australia)

^b The Eye Hospital   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

Author keywords

Cyclosporine; Immunosuppression; Uveitis

Indexed keywords

CYCLOSPORIN A; SIMVASTATIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; FEMALE; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERCHOLESTEROLEMIA; RHABDOMYOLYSIS; TREATMENT WITHDRAWAL; UVEITIS;

AGED; ANTICHOLESTEREMIC AGENTS; CHRONIC DISEASE; CYCLOSPORINE; DRUG INTERACTIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE AGENTS; RHABDOMYOLYSIS; SIMVASTATIN; UVEITIS, POSTERIOR;

EID: 34548321209     PISSN: 09273948     EISSN: 17445078     Source Type: Journal    
DOI: 10.1080/09273940701375147     Document Type: Article

References (5)

1. Jabs DA, Rosenbaum JT, Foster CS, et al. Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol. 2000; 130:492-513.
2. Kim EC, Foster CS. Immunomodulatory therapy for the treatment of ocular inflammatory disease: evidence-based medicine recommendations for use. Int Ophthalmol Clin. 2006; 46:141-164.
3. Hamilton-Craig I. Statin-associated myopathy. Med J Aust. 2001; 175:486-489.
4. Gumprecht J, Zychma M, Grzeszczak W, et al. Simvastatin-induced rhabdomyolysis in a CsA-treated renal transplant recipient. Med Sci Monit. 2003; 9:CS89-CS91.
5. Keogh A, Macdonald P, Kaan A, Aboyoun C, Spratt P, Mundy J. Efficacy and safety of pravastatin vs simvastatin after cardiac transplantation. J Heart Lung Transplant. 2000; 19:529-537.